MUFG Americas’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-200
Closed -$15K 940
2022
Q2
$15K Sell
200
-147
-42% -$11K ﹤0.01% 639
2022
Q1
$31K Buy
347
+147
+74% +$13.6K ﹤0.01% 602
2021
Q4
$22K Buy
+200
New +$24.1K ﹤0.01% 680

Other funds holding XBI

MUFG Americas's XBI Position: Q3 2022 in Review

MUFG Americas sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2022, closing a stake of 200 shares — an estimated $15K sold.

MUFG Americas first reported a position in XBI in Q4 2021 and held it in 3 quarters. The position peaked at $31K in Q1 2022. 704 funds tracked by Wall St. Rank hold XBI as of Q3 2022.

  • MUFG Americas reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2022 after selling out during the quarter.
  • MUFG Americas sold 200 State Street SPDR S&P Biotech ETF shares in Q3 2022, an estimated $15K.
  • MUFG Americas first reported a position in State Street SPDR S&P Biotech ETF in Q4 2021 and held it in 3 quarters.
  • MUFG Americas's State Street SPDR S&P Biotech ETF position peaked at $31K in Q1 2022.
  • 704 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2022.

Based on MUFG Americas's 13F filing for Q3 2022, filed 1 Nov 2022.